Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-9-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-4819
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
129
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
507-8
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9735094-Aged,
pubmed-meshheading:9735094-Anti-Bacterial Agents,
pubmed-meshheading:9735094-Drug Eruptions,
pubmed-meshheading:9735094-Female,
pubmed-meshheading:9735094-Humans,
pubmed-meshheading:9735094-Immunoglobulin A,
pubmed-meshheading:9735094-Skin Diseases, Vesiculobullous,
pubmed-meshheading:9735094-Vancomycin
|
pubmed:year |
1998
|
pubmed:articleTitle |
Vancomycin-associated linear IgA bullous dermatosis.
|
pubmed:publicationType |
Letter,
Case Reports
|